Farletuzumab-MMAE, an antibody-drug conjugate (ADC), combines an FRA-targeted antibody with Monomethyl auristatin E (MMAE) and is utilized in researching non-small cell lung cancer.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
